4//SEC Filing
Tucker John H 4
Accession 0000899243-22-033404
CIK 0001604950other
Filed
Oct 10, 8:00 PM ET
Accepted
Oct 11, 6:06 PM ET
Size
11.9 KB
Accession
0000899243-22-033404
Insider Transaction Report
Form 4
Tucker John H
DirectorPresident and CEO
Transactions
- Tax Payment
Common Stock
2022-10-07$4.98/sh−10,288$51,234→ 78,924 total - Exercise/Conversion
Common Stock
2022-10-07+42,250→ 89,212 total - Exercise/Conversion
Restricted Stock Units
2022-10-07−42,250→ 0 total→ Common Stock (42,250 underlying) - Award
Stock Option (right to buy)
2022-10-07+42,250→ 42,250 totalExercise: $3.25Exp: 2029-02-25→ Common Stock (42,250 underlying)
Footnotes (4)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]The shares reported as disposed were withheld by the Issuer to satisfy tax withholding obligations of the Reporting Person related to the vesting of restricted stock units.
- [F3]On February 25, 2019, the Reporting Person was granted 84,500 restricted stock units (the "RSUs"). One half (1/2) of the RSUs previously vested upon the Issuer's submission of a New Drug Application ("NDA") for its product candidate, FUROSCIX, and the remaining one half (1/2) shall vest upon the Food & Drug Administration's (the "FDA") approval of the NDA. On October 7, 2022, the performance criteria for the second half of the grant was met and 42,250 shares vested. The RSUs have no expiration date.
- [F4]On February 25, 2019, the Reporting Person was granted an option to purchase 84,500 shares of common stock. One half (1/2) of the shares previously vested upon the Issuer's submission of an NDA for its product candidate, FUROSCIX, and the remaining one half (1/2) shall vest upon the FDA's approval of the NDA. On October 7, 2022, the performance criteria for the second half of the grant was met and 42,250 shares vested.
Documents
Issuer
scPharmaceuticals Inc.
CIK 0001604950
Entity typeother
Related Parties
1- filerCIK 0001303480
Filing Metadata
- Form type
- 4
- Filed
- Oct 10, 8:00 PM ET
- Accepted
- Oct 11, 6:06 PM ET
- Size
- 11.9 KB